The intestinal anti-inflammatory activity of esculetin (25 mg/Kg by oral route) in mice DSS-induced intestinal inflammation model was related to a reduction in MPO activity, counteraction of GSH depletion, and reduction in IL-6 production [80]. The gene discussed is MPO; the disease is gastroenteritis.